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Morphological Pattern of Testicular Tumors
M. Shafiq Gill,Sajid H. Shah,Irshad N. Soomro,Naila Kayani,Sheema H. Hasan ( Department of Pathology, The Aga Khan
University Hospital, Karachi. ) 
Abstract 
Objective: To find out the mode of presentation, age distribution and the prevalence of various
histological subtypes of testicular tumors.
Method: All consecutive cases of testicular tumors diagnosed in the department of pathology, the Aga
Khan University Hospital, Karachi, during the period of eight years (1991-98) were included in this
study. Relevant clinical details such as age, clinical presentation and side of involvement of the testis
were also recorded, where available.
Results: During the span of eight years (1991-98), 170 cases of testicular tumors were diagnosed at the
Aga Khan University Hospital, Karachi. Most of the tumors were diagnosed in the third and fourth
decade of life. Scrotal mass or swelling was the predominant mode of presentation. There was a slight
predominance of right- sided testicular tumors. Germ cell tumors constituted 83.5% of all malignant
testicular neoplasms. Amongst these seminoma was the most common (36.5%) tumor followed by
mixed germ cell tumors (28.82%). Yolk-sac tumor was the commonest testicular neoplasm in children
while lvmphoma was the predominant neoplasm in the malignancy in this series correlated with that
reported elderly population.
Conclusion: The overall relative frequency of testicular in the international literature UPMA 50:110,
2000).
Introduction 
Testicular cancer is the commonest malignancy in young males1. The worldwide incidence has been
rising steadily and has more than doubled over the past few decades2. Approximately 95% of malignant
tumors arising in the testes are germ cell tumors3. Although most of these behave aggressively, they are
among the most curable cancers in humans4. More than 90% of patients with newly diagnosed cancer
are cured5,6. Mortality due to these lesions has decreased because of recent advances in their
management with combination chemotherapy and surgery7. Early and accurate diagnosis is important
for successful management of testicular tumors as a delay in diagnosis correlates with higher stage at
the presentation for treatment5,6. This study looks at the prevalence of various histological sub-types of
testicular tumors, presentation and age distribution in our population.
Materials and Methods 
This study included all (n=170) cases of testicular tumors diagnosed in this hospital during a period of
eight years (199 1-98). The WHO classification scheme was used for histologic typing8. Relevant
clinical details such as age, clinical presentation and side of involvement of the testis, were analyzed
along-with histological diagnoses. Ten percent buffered formalin was used as fixative for specimens.
The gross examination of the specimens was performed and adequate representative sections were
obtained according to the guidelines provided by Rosai9.
Paraffin-embedded sections were stained routinely with Haematoxylin and Eosin. PAS (Periodic Acid
Schiff) and reticulin stains were performed where necessary. Immunohistochemical staining was also
done where indicated. The immunomarkers included Cytokeratin, Human Chorionic Gonadotrophin
(HCG), Placental Alkaline Phosphatase (PLAP), Alpha Feto Protein (AFP), Leukocyte Common
Antigen (LCA), 1.-26 (Pan-B) and UCHL-l (Pan-T). All of these monoclonal antibodies are
commercially available and were obtained from DAKO. Denmark.
Results 
During the period 1991-98, 170 cases of testicular cancer were diagnosed. Age of the patients ranged
from 01 year to 84 years with a mean age of 30.94 years. The most common mode of presentation
(Table 1)
was testicular mass or swelling (94.4%), whereas cryptorchidism was seen in 8.4% cases,
gynecomastia in 1 .4% cases and history of testicular trauma was observed in 1.4% of the cases.
Laterality of testicular involvement was known in 127 cases. Sixty six cases (51 .9%) were detected in
the right testis and 59 cases (46.5%) in the left testis. Both testes were involved in two patients only.
Histologically (Table 2),
83.5% testicular tumors were of germ cell type, the rest 16.5% cases were various non-germ cell
tumors. Amongst the germ cell tumors, seminoma (43.66%) was the most common type.
Approximately one third (34.5%) of germ cell malignancies 2 patients presented with testicular mass
alongwith gynecomastia, while in two patients testicular mass was noted and there was history of
testicular trauma as well.
were of mixed type
he age distribution of five leading tumors is shown in Table 3.
The age related data reveals that seminoma was the most common lesion encountered, with 42% of the
patients between 20 to 29 years of age. There was a slight predominance (55.1%) of right-sided tumors.
Bilateral seminoma was seen in one case only.
Mixed germ cell tumor was the second common testicular tumor in frequency, accounting for 28.82%
of all cases. Majority of the patients presented between the ages of 20 to 29 years. A broad spectrum of
histopathological combinations was encountered in this subgroup such as years, with a mean of 26.2
years.
Lymphoma constituted the third major category in this series. Half of the patients were aged 60 years or
above. All cases were of B-cell phenotype as determined by LCA and L-26 (Pan-B) irnmunostaining
embiyona! carcinoma and teratoma, embryonal carcinoma and yolk sac tumor, enibryonal carcinoma,
yolk-sac tumor and teratoma. The ages of the patients ranged from 3 to 50
Yolk sac tumor ranked fourth in this study. 53.8% of the patients were below 4 years of age, making it
the commonest (70%) testicular tumor in pediatric population.
Teratoma was encountered in 12 patients. This included 10 patients with immature teratoma and 2
patients with mature teratoma exhibiting focal malignant transformation.
Discussion 
In Western countries cancer of the testis is the most common solid malignancy in men age 15-35 years,
being responsible for approximately 10% of all cancer related deaths in this age group3,10,11. Its
incidence in United States is approximately 6 per 100,0003. One study has reported that testicular
tumors comprise 3.8% of all malignancies in Pakistan12. In Pakistan central tumor registry is non-
existent making it difficult to know the true prevalence of tumors in our country. There has been a
single study looking at the frequency and histological types of testicular tumors in Pakistan13. However
data presented was mostly from northern part of Pakistan and it comprised of relatively smaller number
of patients. This could be the reason for differences in the relative distribution of some of the testicular
tumors when compared wit the present study (Table 4).
Testis has a complex histologic composition, testicular tumors as a consequence, may differentiate
along a multitude of pathways14. In a large epidemiologic survey of about 34,000 testicular tumors in
nine northern Europian states, where these tumors are reported to have a higher incidence, it was
demonstrated that the highest age-related incidences were to be found in two age groups, 25-29 years
and 30-34 years15. Another study from the neighboring state of India revealed similar age incidence16.
In the present study (Table 2). the mean age at presentation for mixed germ cell tumors was 26.2 years
and for seminoma, 34.3 years. This finding is consistent with the reported in international literature.
In general testicular tumors present as a painless mass or swelling17. Majority of the patients in our
study also presented with testicular mass or swelling (Table 1). Cryptorchildism is reported to be a
predisposing factor in the development of germ cell tumors in testes. Literature review reveals that a
cryptorchid testis has a fivefold to tenfold increased risk of developing a malignant tumor as compared
with the normally placed testis18. Conversely, approximately 11% of testicular tumors are associated
with cryptorchidism, seminoma being the commonest19,20. In the patients with unilateral cryptorch
idism, the contralateral, normally descended testis may also undergo malignant transformation3. In our
study. crvptorchidism was seen in 8.4% of cases, half of these were seminomas.
Gynecomastia is rare in the patients with testicular cancer and is generally considered an unfavorable
prognostic factor21. In our series. only two patients presented with gynecomastia.
Lymphornas comprise only 5% of all testicular neoplasms and constitute the most corn mon testicular
malignancy in elderly population3. The diffuse large cell variety is the predominant histologic type.
These tumors have a grave prognosis22. In this study l\\rnphoma was the most common non-germ cell
tumor, accounting for 8.23% of all testicular neoplasms.
We concluded that the morphologic pattern of testicular tumors in our series is sim lIar to that reported
in the international literature.
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